Fluorescent Immunoassay Market Analysis and Report by 2031
The fluorescent immunoassay market size is projected to reach US$ 4.51 billion by 2031 from US$ 2.81 billion in 2023. The market is expected to register a CAGR of 5.8% during 2023–2031. Portable fluorescent immunoassay devices for point of care testing are likely to remain key trends in the market.
Fluorescent Immunoassay Market Analysis
Growing prevalence of infectious diseases is the key factor driving the market's growth. Fluorescent immunoassays are widely used in diagnosis of infectious diseases such as COVID-19, HIV, Hepatitis among others. As per the World Health Organization (WHO), in December 2023, 39.9 million patients were living with HIV of which 1.4 million were children (0–14 years old) and 38.6 million were adults (15+ years old).
Fluorescent Immunoassay Market Overview
Increasing prevalence of infectious and chronic diseases, technological developments such as multiplexing capabilities, automate fluorescence immunoassay systems, development of portable devices, expanding applications of fluorescent immunoassays in areas such as oncology, neurological diseases, among others, integration with digital health, streamline regulatory pathways, favourable reimbursement scenario, and growing research and development activities to develop new assay and kits are factors driving the growth of the fluorescent immunoassay market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fluorescent Immunoassay Market: Strategic Insights
Market Size Value in US$ 2,578.66 Million in 2021 Market Size Value by US$ 3,778.78 Million by 2028 Growth rate CAGR of 5.6% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fluorescent Immunoassay Market: Strategic Insights
Market Size Value in | US$ 2,578.66 Million in 2021 |
Market Size Value by | US$ 3,778.78 Million by 2028 |
Growth rate | CAGR of 5.6% from 2021 to 2028 |
Forecast Period | 2021-2028 |
Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystFluorescent Immunoassay Market Drivers and Opportunities
Rising Prevalence of Cancer is likely to Increase the Demand for Fluorescent Immunoassay.
Fluorescent immunoassays help detect cancer biomarkers, which help in early cancer screening, diagnosis, and prognosis. As per the American Cancer Society, there were around 20 million cancer cases across the globe in 2022, and the number of cancer cases is expected to reach 35 million by 2050. Such a huge burden of cancer cases around the world is likely to increase the demand for fluorescent immunoassay.
Emerging Markets
Growing healthcare expenditure, improving healthcare infrastructure, and rising prevalence of infectious and chronic diseases are likely to create growth opportunities for the fluorescent immunoassay market in emerging markets. For instance, the Ministry of Health and Family Welfare allocated Rs. 90,659 crore (US$ 10.93 billion), which is an increase of 1.69% compared to Rs. 89,155 crore (US$ 10.75 billion) in 2023-24.
Fluorescent Immunoassay Market Report Segmentation Analysis
Key segments that contributed to the derivation of the fluorescent immunoassay market analysis are product, and end user.
- The global fluorescent immunoassay market, based on product type is segmented into ELISA, rapid lateral flow immunoassay and others. In 2023, the ELISA segment held the largest share of the market. Moreover, the same segment is also expected to witness fastest growth during the forecast period, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
- Based on application, the fluorescent immunoassay market is segmented into infectious diseases, oncology, cardiovascular diseases, others. In 2021, the infectious diseases segment held the largest share of the market and the same segment is also expected to witness fastest growth duringthe forecast period, owing to the rise in the prevalence of infectious diseases across the globe.
- Based on route of administration, the global fluorescent immunoassay market is divided into intravenous, subcutaneous, and other applications. The intravenous segment held the largest share of the market in 2023 and is expected to grow at the highest CAGR during the forecast period.
- By end-user, the global fluorescent immunoassay market is segmented into Hospitals & Clinics, diagnostic centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and others. The hospitals segment held the largest share of the market in 2023 and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Fluorescent Immunoassay Market Share Analysis by Geography
The geographic scope of the fluorescent immunoassay market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The North American region holds the largest market share, whereas the Asia Pacific region is the fastest-growing region. The growth of the market in North America is mainly due to the rising demand for fluorescent immunoassays as the US and Canada are experiencing growing numbers of research and development activities and rising investments in clinical diagnostic businesses by key market players. Moreover, Asia Pacific is the fastest-growing global market for fluorescent immunoassays. China, India, and Japan are three major contributors to the growth of the market. The factors contributing to the growth of the fluorescent immunoassay market in these countries are the rise in cases of chronic diseases over the years. Countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the healthcare sector.
Fluorescent Immunoassay Market Report Scope
Fluorescent Immunoassay Market News and Recent Developments
The fluorescent immunoassay market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the fluorescent immunoassay market are listed below:
- Roche announced that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of SARS-CoV-2 infections. The laboratory-based Elecsys SARS-CoV-2 Antigen test had earlier received CE mark and has recently obtained the import license from CDSCO (Source: F. Hoffmann-La Roche Ltd., Press Release, June 2021)
- Ortho Clinical Diagnostics announced its quantitative COVID-19 IgG antibody test achieved CE Mark. Ortho’s VITROS Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization SARS-CoV-2 serological methods. (Source: Ortho Clinical Diagnostics, Newsletter, May 2021)
- Ortho Clinical Diagnostics announced the US FDA granted Emergency Use Authorization to its second COVID-19 antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test (COVID-19 IgG antibody test). (Source: Ortho Clinical Diagnostics, Newsletter, April 2021)
Fluorescent Immunoassay Market Report Coverage and Deliverables
The “Fluorescent Immunoassay Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Fluorescent immunoassay market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Fluorescent immunoassay market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Fluorescent immunoassay market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the fluorescent immunoassay market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The fluorescent immunoassay market is estimated to grow with a CAGR of 5.8% from 2023 to 2031.
The estimated value of the fluorescent immunoassay market by 2031 is US$ 4.51 billion
The fluorescent immunoassay market majorly consists of the players such as Abbott, BD, bioMerieux SA, F. Hoffman-La Roche Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Quidel Corp., Ortho Clinical Diagnostics Holdings plc, and Danaher among others.
Portable fluorescent immunoassay devices for point of care testing are likely to remain key trends in the market.
Growing prevalence of infectious and chronic diseases across the globe and technological developments such as automated systems are expected to boost the market growth over the years. However, disadvantages of fluorescent immunoassays are likely to have a negative impact on the growth of the market in the coming years.
North America dominated the fluorescent immunoassay market in 2023
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Fluorescent Immunoassay Market
Aug 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Aug 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Aug 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2024
Bioreactors Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization), and Geography
Aug 2024
Poultry Diagnostics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others), and Geography
Aug 2024
ELISA Diagnostics Tests Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography
Aug 2024
Direct-To-Consumer Genetic Testing Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography
Aug 2024
Transient Protein Expression Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)